About: Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1990 (uk) im März 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1990 (ast) ശാസ്ത്രപ്രബന്ധം (ml) scientific article published on 01 March 1990 (en)
publication date	wds:Q68083954-20602072-6AA6-46C3-BB55-7684A2915D6A
publication date	1990-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68083954-C1CA573C-DF19-4838-B1B5-52EA855AA9FF
language of work or name	English
author name string	wds:Q68083954-23B713FB-D10B-485F-A0F7-695A37A305D4 wds:Q68083954-3276D73B-384B-4B3B-BC59-CAA33BBC4ECF wds:Q68083954-390E22CC-24AB-4FBE-BF3C-E6BC71480198 wds:Q68083954-61D14CA5-233E-4EFF-97F5-7B30ACA8AC4A wds:Q68083954-6F559BC3-1E6B-4D8E-B62F-E50D9CDD4571 wds:Q68083954-8D785BAB-CB7A-4463-9ABB-54588413BE30 wds:Q68083954-B91A2945-010F-4547-AA78-F9034203CF70 wds:Q68083954-BECBE7EC-C02D-456E-8336-7B413785F910 wds:Q68083954-E5A02C22-E328-45AD-AA38-122EA5E83223
author name string	I C Macdougall M E Davies M J Saunders J D Williams K A Fox G A Coles N P Lewis R D Hutton D L Cochlin
rdfs:label	Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (en) Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (nl)
skos:prefLabel	Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (en) Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (nl)
name	Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (en) Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (nl)
title	wds:Q68083954-A738779E-5AB3-400E-B892-87128C0200E2
title	Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin (en)
page(s)	wds:Q68083954-F2B4F386-746A-4DAE-BD49-1D84BBFF12D7
page(s)	489-493
instance of	wds:Q68083954-EF5A6C9C-8446-4D56-BCE6-AE5490E40949
instance of	scholarly article
main subject	wds:Q68083954-2CC27CD5-E5D9-48C7-8058-07153F6EA3F1
main subject	wd:Q218706
PubMed ID	wds:Q68083954-53BD7500-A441-493D-A0CC-F599D8B11CF2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1968526
PubMed ID	1968526
published in	wds:Q68083954-57F2FEE1-28C3-448B-86CA-0C31990E2825
published in	The Lancet
issue	wds:Q68083954-8A0C28B9-D244-47FE-831A-C4520A0CB3DB
volume	wds:Q68083954-F9C6290A-5BD2-4A08-862D-84D4928D12B0
issue	8688
volume	335
DOI	wds:Q68083954-2E988E63-84C1-4578-9B70-C058D977DAE1
DOI	http://dx.doi.org/10.1016/0140-6736(90)90733-L
DOI	10.1016/0140-6736(90)90733-L
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68083954
is cites work of	Cardiovascular risk factors in chronic renal failure and hemodialysis populations Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Syndrome X and hyperventilation Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 The prevalence of anemia in chronic heart failure Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis Epoetin Beta Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life Association of chronic kidney disease and anemia with physical capacity: the heart and soul study The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. Erythropoietin in chronic renal failure Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Cardiorenal syndrome: the emerging role of protein-bound uremic toxins Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance hemodialysis. Physical functioning and exercise capacity in patients on dialysis. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients Nephrology, dialysis and transplantation Recombinant erythropoietin (Epogen) improves cardiac exercise performance in children with end-stage renal disease Cardiac disease in chronic uremia: management Worsening of left ventricular diastolic function during long-term correction of anemia with erythropoietin in chronic hemodialysis patients--an assessment by radionuclide ventriculography at rest and exercise A review of quality of life in chronic renal failure Exercise as an Adjunct Therapy In Chronic Kidney Disease. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer The use of erythropoietin in renal failure Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid. Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients Impact of chronic kidney disease and anemia on physical function in patients with chronic heart failure Cellular bioenergetics after erythropoietin therapy in chronic renal failure. Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients Haematology Neither Hematocrit Normalization nor Exercise Training Restores Oxygen Consumption to Normal Levels in Hemodialysis Patients Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron Gradual reduction in exercise capacity in chronic kidney disease is associated with systemic oxygen delivery factors Left ventricular hypertrophy: a surrogate end point or correlate of cardiovascular events in kidney disease? Transfusion and the use of blood products Pharmacological approaches to reduce perioperative transfusion requirements in the aged

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software